THERAVANCE INC's ticker is and the CUSIP is 88338TAB0. A total of 20 filers reported holding THERAVANCE INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $499 | +1.4% | 1,000 | 0.0% | 0.00% | – |
| Q2 2022 | $492 | -8.4% | 1,000 | 0.0% | 0.00% | – |
| Q3 2021 | $537 | +5.5% | 1,000 | 0.0% | 0.00% | – |
| Q2 2021 | $509 | +1.4% | 1,000 | 0.0% | 0.00% | – |
| Q1 2021 | $502 | -1.2% | 1,000 | 0.0% | 0.00% | – |
| Q4 2020 | $508 | +5.8% | 1,000 | 0.0% | 0.00% | – |
| Q3 2020 | $480 | -3.2% | 1,000 | 0.0% | 0.00% | – |
| Q2 2020 | $496 | +6.4% | 1,000 | 0.0% | 0.00% | – |
| Q1 2020 | $466 | -7.4% | 1,000 | 0.0% | 0.00% | – |
| Q4 2019 | $503 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $1 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |